evidence table

Beta Glucan Blood Pressure Randomized Trial Evidence Table

Structured evidence table for Beta Glucan Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Beta Glucan Blood Pressure Randomized TrialThis research will strengthen the evidence base supporting the use of M-Gard® as a supplement for the management of AR.2Briskey D (2026)Efficacy and safety of a particulate yeast β-glucan preparation in the treatment of seasonal allergic rhinitis (BETALL): a randomised placebo-controlled crossover trial protocol.
Beta Glucan Blood Pressure Randomized TrialBackground Allergic rhinitis (AR) has been shown to be a significant global health burden.2Briskey D (2026)Efficacy and safety of a particulate yeast β-glucan preparation in the treatment of seasonal allergic rhinitis (BETALL): a randomised placebo-controlled crossover trial protocol.
Beta Glucan Blood Pressure Randomized TrialDespite the existence of pharmacological treatments, mainly antihistamines, nasal corticosteroids, and decongestants, many individuals with seasonal allergies turn to alternative herbal medicines and nutritional supplements for the management of symptoms.2Briskey D (2026)Efficacy and safety of a particulate yeast β-glucan preparation in the treatment of seasonal allergic rhinitis (BETALL): a randomised placebo-controlled crossover trial protocol.
Beta Glucan Blood Pressure Randomized TrialTo enhance solubility, β-1,3/1,6-glucan oligosaccharides were developed from polysaccharides through gamma-irradiation.4Rungraung N (2026)Differential Safety and Lipid Control Efficacy of β-1,3/1,6-Glucan Oligosaccharides and Polysaccharides Derived From <i>Ophiocordyceps dipterigena</i> BCC 2073 in Healthy Volunteers.
Beta Glucan Blood Pressure Randomized TrialNevertheless, whether their safety and efficacy profiles are different remains unclear.4Rungraung N (2026)Differential Safety and Lipid Control Efficacy of β-1,3/1,6-Glucan Oligosaccharides and Polysaccharides Derived From <i>Ophiocordyceps dipterigena</i> BCC 2073 in Healthy Volunteers.
topicBeta Glucan Blood Pressure Randomized Trial
claimThis research will strengthen the evidence base supporting the use of M-Gard® as a supplement for the management of AR.
evidence level2
citationBriskey D (2026)
sourceEfficacy and safety of a particulate yeast β-glucan preparation in the treatment of seasonal allergic rhinitis (BETALL): a randomised placebo-controlled crossover trial protocol.
topicBeta Glucan Blood Pressure Randomized Trial
claimBackground Allergic rhinitis (AR) has been shown to be a significant global health burden.
evidence level2
citationBriskey D (2026)
sourceEfficacy and safety of a particulate yeast β-glucan preparation in the treatment of seasonal allergic rhinitis (BETALL): a randomised placebo-controlled crossover trial protocol.
topicBeta Glucan Blood Pressure Randomized Trial
claimDespite the existence of pharmacological treatments, mainly antihistamines, nasal corticosteroids, and decongestants, many individuals with seasonal allergies turn to alternative herbal medicines and nutritional supplements for the management of symptoms.
evidence level2
citationBriskey D (2026)
sourceEfficacy and safety of a particulate yeast β-glucan preparation in the treatment of seasonal allergic rhinitis (BETALL): a randomised placebo-controlled crossover trial protocol.
topicBeta Glucan Blood Pressure Randomized Trial
claimTo enhance solubility, β-1,3/1,6-glucan oligosaccharides were developed from polysaccharides through gamma-irradiation.
evidence level4
citationRungraung N (2026)
sourceDifferential Safety and Lipid Control Efficacy of β-1,3/1,6-Glucan Oligosaccharides and Polysaccharides Derived From <i>Ophiocordyceps dipterigena</i> BCC 2073 in Healthy Volunteers.
topicBeta Glucan Blood Pressure Randomized Trial
claimNevertheless, whether their safety and efficacy profiles are different remains unclear.
evidence level4
citationRungraung N (2026)
sourceDifferential Safety and Lipid Control Efficacy of β-1,3/1,6-Glucan Oligosaccharides and Polysaccharides Derived From <i>Ophiocordyceps dipterigena</i> BCC 2073 in Healthy Volunteers.

Learn next

Related evidence and supplement guides

GuideBeta Glucan Blood Pressure Randomized Trial: What the Evidence SaysBeta Glucan Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidenc...GuideBeta-glucan Blood Pressure Meta-analysis: What the Evidence SaysBeta-glucan Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence d...GuideChokeberry Blood Pressure Randomized Trial: What the Evidence SaysChokeberry Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence...GuideHibiscus Blood Pressure Randomized Trial: What the Evidence SaysHibiscus Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence d...AnswerDoes Beta Glucan Blood Pressure Randomized Trial work?Beta Glucan Blood Pressure Randomized Trial has evidence relevant to strength of evidence and wh...AnswerIs Beta Glucan Blood Pressure Randomized Trial safe?Beta Glucan Blood Pressure Randomized Trial has evidence relevant to safety, limits, and clinici...AnswerWhat does the evidence say about Beta Glucan Blood Pressure Randomized Trial?Beta Glucan Blood Pressure Randomized Trial has evidence relevant to benefits, uncertainty, and...AnswerDoes Beta-Glucan Blood Pressure Meta-Analysis work?Beta-Glucan Blood Pressure Meta-Analysis has evidence relevant to strength of evidence and what...

Source documents

  1. Efficacy and safety of a particulate yeast β-glucan preparation in the treatment of seasonal allergic rhinitis (BETALL): a randomised placebo-controlled crossover trial protocol.
  2. Differential Safety and Lipid Control Efficacy of β-1,3/1,6-Glucan Oligosaccharides and Polysaccharides Derived From <i>Ophiocordyceps dipterigena</i> BCC 2073 in Healthy Volunteers.